Industry Research Reports

Home > Reports > Pharma & Healthcare > Global GMP Interleukin Market Research Report 2024

Global GMP Interleukin Market Research Report 2024

Industry: Pharma & Healthcare

Published: 2024-01-10

Pages: 80 Pages

Report ld: 2171311

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Interleukins are a group of cytokines (secreted proteins and signal molecules) that were first seen to be expressed by white blood cells (leukocytes).

The global GMP Interleukin market was valued at US$ 28 million in 2023 and is anticipated to reach US$ 52 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.

GMP Interleukin Market Size

M= millions and B=billions

A significant driver in the GMP Cytokines market is the expanding use of cytokines in immunotherapy and biopharmaceutical research. Cytokines play a crucial role in regulating immune responses and have therapeutic potential in various diseases, including cancer and autoimmune disorders. However, a notable challenge in this market is the need for rigorous quality control and adherence to Good Manufacturing Practices (GMP) standards. Ensuring that cytokine production processes meet strict quality, safety, and purity criteria while complying with regulatory guidelines poses a significant challenge. Manufacturers must prioritize GMP-compliant manufacturing processes, quality assurance, and regulatory compliance to deliver safe and effective cytokine-based therapeutics, addressing the growing demand for innovative immunotherapies and biopharmaceutical products.

This report aims to provide a comprehensive presentation of the global market for GMP Interleukin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Interleukin.

Report Scope
The GMP Interleukin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Interleukin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GMP Interleukin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global GMP Interleukin Market Research Report 2024
Forecasted Market Size in 2030
US$ 52 million
CAGR(2024-2030)
9.2%
Market Size Available for Years
2019-2030
Global GMP Interleukin Companies Covered
Miltenyi Biotec, Bio-Techne, GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological, Creative Bioarray, Akron Biotech, Almog
Global GMP Interleukin Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global GMP Interleukin Market, Segment by Type
25μg

50μg

Others
Global GMP Interleukin Market, Segment by Application
Cell/Gene Therapy

Tissue-Engineered Products

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Interleukin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global GMP Interleukin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 25μg
        1.2.3 50μg
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global GMP Interleukin Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Cell/Gene Therapy
        1.3.3 Tissue-Engineered Products
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global GMP Interleukin Market Perspective (2019-2030)
    2.2 GMP Interleukin Growth Trends by Region
        2.2.1 Global GMP Interleukin Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 GMP Interleukin Historic Market Size by Region (2019-2024)
        2.2.3 GMP Interleukin Forecasted Market Size by Region (2025-2030)
    2.3 GMP Interleukin Market Dynamics
        2.3.1 GMP Interleukin Industry Trends
        2.3.2 GMP Interleukin Market Drivers
        2.3.3 GMP Interleukin Market Challenges
        2.3.4 GMP Interleukin Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top GMP Interleukin Players by Revenue
        3.1.1 Global Top GMP Interleukin Players by Revenue (2019-2024)
        3.1.2 Global GMP Interleukin Revenue Market Share by Players (2019-2024)
    3.2 Global GMP Interleukin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by GMP Interleukin Revenue
    3.4 Global GMP Interleukin Market Concentration Ratio
        3.4.1 Global GMP Interleukin Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by GMP Interleukin Revenue in 2023
    3.5 GMP Interleukin Key Players Head office and Area Served
    3.6 Key Players GMP Interleukin Product Solution and Service
    3.7 Date of Enter into GMP Interleukin Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 GMP Interleukin Breakdown Data by Type
    4.1 Global GMP Interleukin Historic Market Size by Type (2019-2024)
    4.2 Global GMP Interleukin Forecasted Market Size by Type (2025-2030)

 5 GMP Interleukin Breakdown Data by Application
    5.1 Global GMP Interleukin Historic Market Size by Application (2019-2024)
    5.2 Global GMP Interleukin Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America GMP Interleukin Market Size (2019-2030)
    6.2 North America GMP Interleukin Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America GMP Interleukin Market Size by Country (2019-2024)
    6.4 North America GMP Interleukin Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe GMP Interleukin Market Size (2019-2030)
    7.2 Europe GMP Interleukin Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe GMP Interleukin Market Size by Country (2019-2024)
    7.4 Europe GMP Interleukin Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific GMP Interleukin Market Size (2019-2030)
    8.2 Asia-Pacific GMP Interleukin Market Growth Rate by Region: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific GMP Interleukin Market Size by Region (2019-2024)
    8.4 Asia-Pacific GMP Interleukin Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America GMP Interleukin Market Size (2019-2030)
    9.2 Latin America GMP Interleukin Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America GMP Interleukin Market Size by Country (2019-2024)
    9.4 Latin America GMP Interleukin Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa GMP Interleukin Market Size (2019-2030)
    10.2 Middle East & Africa GMP Interleukin Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa GMP Interleukin Market Size by Country (2019-2024)
    10.4 Middle East & Africa GMP Interleukin Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Miltenyi Biotec
        11.1.1 Miltenyi Biotec Company Detail
        11.1.2 Miltenyi Biotec Business Overview
        11.1.3 Miltenyi Biotec GMP Interleukin Introduction
        11.1.4 Miltenyi Biotec Revenue in GMP Interleukin Business (2019-2024)
        11.1.5 Miltenyi Biotec Recent Development
    11.2 Bio-Techne
        11.2.1 Bio-Techne Company Detail
        11.2.2 Bio-Techne Business Overview
        11.2.3 Bio-Techne GMP Interleukin Introduction
        11.2.4 Bio-Techne Revenue in GMP Interleukin Business (2019-2024)
        11.2.5 Bio-Techne Recent Development
    11.3 GE Healthcare
        11.3.1 GE Healthcare Company Detail
        11.3.2 GE Healthcare Business Overview
        11.3.3 GE Healthcare GMP Interleukin Introduction
        11.3.4 GE Healthcare Revenue in GMP Interleukin Business (2019-2024)
        11.3.5 GE Healthcare Recent Development
    11.4 Lonza
        11.4.1 Lonza Company Detail
        11.4.2 Lonza Business Overview
        11.4.3 Lonza GMP Interleukin Introduction
        11.4.4 Lonza Revenue in GMP Interleukin Business (2019-2024)
        11.4.5 Lonza Recent Development
    11.5 CellGenix
        11.5.1 CellGenix Company Detail
        11.5.2 CellGenix Business Overview
        11.5.3 CellGenix GMP Interleukin Introduction
        11.5.4 CellGenix Revenue in GMP Interleukin Business (2019-2024)
        11.5.5 CellGenix Recent Development
    11.6 ReproCELL
        11.6.1 ReproCELL Company Detail
        11.6.2 ReproCELL Business Overview
        11.6.3 ReproCELL GMP Interleukin Introduction
        11.6.4 ReproCELL Revenue in GMP Interleukin Business (2019-2024)
        11.6.5 ReproCELL Recent Development
    11.7 PeproTech
        11.7.1 PeproTech Company Detail
        11.7.2 PeproTech Business Overview
        11.7.3 PeproTech GMP Interleukin Introduction
        11.7.4 PeproTech Revenue in GMP Interleukin Business (2019-2024)
        11.7.5 PeproTech Recent Development
    11.8 Sino Biological
        11.8.1 Sino Biological Company Detail
        11.8.2 Sino Biological Business Overview
        11.8.3 Sino Biological GMP Interleukin Introduction
        11.8.4 Sino Biological Revenue in GMP Interleukin Business (2019-2024)
        11.8.5 Sino Biological Recent Development
    11.9 Creative Bioarray
        11.9.1 Creative Bioarray Company Detail
        11.9.2 Creative Bioarray Business Overview
        11.9.3 Creative Bioarray GMP Interleukin Introduction
        11.9.4 Creative Bioarray Revenue in GMP Interleukin Business (2019-2024)
        11.9.5 Creative Bioarray Recent Development
    11.10 Akron Biotech
        11.10.1 Akron Biotech Company Detail
        11.10.2 Akron Biotech Business Overview
        11.10.3 Akron Biotech GMP Interleukin Introduction
        11.10.4 Akron Biotech Revenue in GMP Interleukin Business (2019-2024)
        11.10.5 Akron Biotech Recent Development
    11.11 Almog
        11.11.1 Almog Company Detail
        11.11.2 Almog Business Overview
        11.11.3 Almog GMP Interleukin Introduction
        11.11.4 Almog Revenue in GMP Interleukin Business (2019-2024)
        11.11.5 Almog Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global GMP Interleukin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of 25μg
    Table 3. Key Players of 50μg
    Table 4. Key Players of Others
    Table 5. Global GMP Interleukin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global GMP Interleukin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global GMP Interleukin Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global GMP Interleukin Market Share by Region (2019-2024)
    Table 9. Global GMP Interleukin Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global GMP Interleukin Market Share by Region (2025-2030)
    Table 11. GMP Interleukin Market Trends
    Table 12. GMP Interleukin Market Drivers
    Table 13. GMP Interleukin Market Challenges
    Table 14. GMP Interleukin Market Restraints
    Table 15. Global GMP Interleukin Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global GMP Interleukin Market Share by Players (2019-2024)
    Table 17. Global Top GMP Interleukin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Interleukin as of 2023)
    Table 18. Ranking of Global Top GMP Interleukin Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by GMP Interleukin Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players GMP Interleukin Product Solution and Service
    Table 22. Date of Enter into GMP Interleukin Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global GMP Interleukin Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global GMP Interleukin Revenue Market Share by Type (2019-2024)
    Table 26. Global GMP Interleukin Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global GMP Interleukin Revenue Market Share by Type (2025-2030)
    Table 28. Global GMP Interleukin Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global GMP Interleukin Revenue Market Share by Application (2019-2024)
    Table 30. Global GMP Interleukin Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global GMP Interleukin Revenue Market Share by Application (2025-2030)
    Table 32. North America GMP Interleukin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America GMP Interleukin Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America GMP Interleukin Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe GMP Interleukin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe GMP Interleukin Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe GMP Interleukin Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific GMP Interleukin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific GMP Interleukin Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific GMP Interleukin Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America GMP Interleukin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America GMP Interleukin Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America GMP Interleukin Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa GMP Interleukin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa GMP Interleukin Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa GMP Interleukin Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Miltenyi Biotec Company Detail
    Table 48. Miltenyi Biotec Business Overview
    Table 49. Miltenyi Biotec GMP Interleukin Product
    Table 50. Miltenyi Biotec Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 51. Miltenyi Biotec Recent Development
    Table 52. Bio-Techne Company Detail
    Table 53. Bio-Techne Business Overview
    Table 54. Bio-Techne GMP Interleukin Product
    Table 55. Bio-Techne Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 56. Bio-Techne Recent Development
    Table 57. GE Healthcare Company Detail
    Table 58. GE Healthcare Business Overview
    Table 59. GE Healthcare GMP Interleukin Product
    Table 60. GE Healthcare Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 61. GE Healthcare Recent Development
    Table 62. Lonza Company Detail
    Table 63. Lonza Business Overview
    Table 64. Lonza GMP Interleukin Product
    Table 65. Lonza Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 66. Lonza Recent Development
    Table 67. CellGenix Company Detail
    Table 68. CellGenix Business Overview
    Table 69. CellGenix GMP Interleukin Product
    Table 70. CellGenix Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 71. CellGenix Recent Development
    Table 72. ReproCELL Company Detail
    Table 73. ReproCELL Business Overview
    Table 74. ReproCELL GMP Interleukin Product
    Table 75. ReproCELL Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 76. ReproCELL Recent Development
    Table 77. PeproTech Company Detail
    Table 78. PeproTech Business Overview
    Table 79. PeproTech GMP Interleukin Product
    Table 80. PeproTech Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 81. PeproTech Recent Development
    Table 82. Sino Biological Company Detail
    Table 83. Sino Biological Business Overview
    Table 84. Sino Biological GMP Interleukin Product
    Table 85. Sino Biological Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 86. Sino Biological Recent Development
    Table 87. Creative Bioarray Company Detail
    Table 88. Creative Bioarray Business Overview
    Table 89. Creative Bioarray GMP Interleukin Product
    Table 90. Creative Bioarray Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 91. Creative Bioarray Recent Development
    Table 92. Akron Biotech Company Detail
    Table 93. Akron Biotech Business Overview
    Table 94. Akron Biotech GMP Interleukin Product
    Table 95. Akron Biotech Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 96. Akron Biotech Recent Development
    Table 97. Almog Company Detail
    Table 98. Almog Business Overview
    Table 99. Almog GMP Interleukin Product
    Table 100. Almog Revenue in GMP Interleukin Business (2019-2024) & (US$ Million)
    Table 101. Almog Recent Development
    Table 102. Research Programs/Design for This Report
    Table 103. Key Data Information from Secondary Sources
    Table 104. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global GMP Interleukin Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global GMP Interleukin Market Share by Type: 2023 VS 2030
    Figure 3. 25μg Features
    Figure 4. 50μg Features
    Figure 5. Others Features
    Figure 6. Global GMP Interleukin Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global GMP Interleukin Market Share by Application: 2023 VS 2030
    Figure 8. Cell/Gene Therapy Case Studies
    Figure 9. Tissue-Engineered Products Case Studies
    Figure 10. Others Case Studies
    Figure 11. GMP Interleukin Report Years Considered
    Figure 12. Global GMP Interleukin Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global GMP Interleukin Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global GMP Interleukin Market Share by Region: 2023 VS 2030
    Figure 15. Global GMP Interleukin Market Share by Players in 2023
    Figure 16. Global Top GMP Interleukin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Interleukin as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by GMP Interleukin Revenue in 2023
    Figure 18. North America GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America GMP Interleukin Market Share by Country (2019-2030)
    Figure 20. United States GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe GMP Interleukin Market Share by Country (2019-2030)
    Figure 24. Germany GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific GMP Interleukin Market Share by Region (2019-2030)
    Figure 32. China GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America GMP Interleukin Market Share by Country (2019-2030)
    Figure 40. Mexico GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa GMP Interleukin Market Share by Country (2019-2030)
    Figure 44. Turkey GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia GMP Interleukin Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Miltenyi Biotec Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 47. Bio-Techne Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 48. GE Healthcare Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 49. Lonza Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 50. CellGenix Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 51. ReproCELL Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 52. PeproTech Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 53. Sino Biological Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 54. Creative Bioarray Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 55. Akron Biotech Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 56. Almog Revenue Growth Rate in GMP Interleukin Business (2019-2024)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed

Description

Interleukins are a group of cytokines (secreted proteins and signal molecules) that were first seen to be expressed by white blood cells (leukocytes).

The global GMP Interleukin market was valued at US$ 28 million in 2023 and is anticipated to reach US$ 52 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Interleukin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Industry: Pharma & Healthcare

Published: 2024-01-10

Pages: 80 Pages

Report ld: 2171311

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 2900.00

Multi Users License

USD 4350.00

Corporate Users License